OnCo
institutionsInstitution

Society of Gynecologic Oncology

aka SGO

The US society of gynaecologic oncologists, whose Annual Meeting on Women's Cancer is where the PARP inhibitor and immunotherapy trials in ovarian, endometrial and cervical cancer are presented.

Founded in 1969, SGO represents more than 2,000 gynaecologic oncologists, surgeons who also deliver systemic therapy, and allied professionals. Its Annual Meeting on Women's Cancer each March hosts the major trials in ovarian, endometrial, cervical and vulvar cancer (PAOLA-1, RUBY, NRG-GY018, KEYNOTE-A18 and MIRASOL were presented at SGO or the concurrent plenaries), and it publishes Gynecologic Oncology and Gynecologic Oncology Reports. SGO issues clinical practice statements on genetic testing, HPV vaccination, minimally invasive surgery after LACC, and molecular classification of endometrial cancer, and it runs the Foundation for Women's Cancer, advocacy on screening and the Winter Meeting for translational science.

Location
Chicago, IL, US
Type
consortium
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#83 · 36 points (0 Newsweek + 0 NCI + 36 from 18 linked objects) · ranking

Programmes

4top
  • Annual Meeting on Women's Cancer
  • Gynecologic Oncology journal
  • Clinical practice statements
  • Foundation for Women's Cancer

People

1top

Connected

19top

Pages like this

not linked directly; found by shared links